|
441 |
Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia
Enthalten in CNS drugs Bd. 25, 29.8.2012, Nr. 11, date:11.2011: 933-969
|
|
|
|
442 |
Pharmacokinetic and Pharmacodynamic Parameters of Antimicrobials
Enthalten in Clinical pharmacokinetics Bd. 48, 13.9.2012, Nr. 8, date:8.2009: 517-528
|
|
|
|
443 |
Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
Enthalten in Clinical pharmacokinetics Bd. 51, 13.12.2012, Nr. 6, date:6.2012: e1-e18
|
|
|
|
444 |
Pharmacokinetic Interactions between Etravirine and Non-Antiretroviral Drugs
Enthalten in Clinical pharmacokinetics Bd. 50, 30.9.2012, Nr. 1, date:1.2011: 25-39
|
|
|
|
445 |
Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing
Enthalten in Clinical pharmacokinetics Bd. 50, 30.9.2012, Nr. 1, date:1.2011: 65-74
|
|
|
|
446 |
Pharmacokinetics and Pharmacodynamics of Pegfilgrastim
Enthalten in Clinical pharmacokinetics Bd. 50, 13.9.2012, Nr. 5, date:5.2011: 295-306
|
|
|
|
447 |
Pharmacokinetics and Pharmacodynamics of Single Rising Intravenous Doses (0.5mg–10mg) and Determination of Absolute Bioavailability of the Dipeptidyl Peptidase-4 Inhibitor Linagliptin (BI 1356) in Healthy Male Subjects
Enthalten in Clinical pharmacokinetics Bd. 49, 30.9.2012, Nr. 12, date:12.2010: 829-840
|
|
|
|
448 |
Pharmacokinetics and Pharmacodynamics of the Erythropoietin Mimetibody™ Construct CNTO 528 in Healthy Subjects
Enthalten in Clinical pharmacokinetics Bd. 48, 14.10.2012, Nr. 9, date:9.2009: 601-613
|
|
|
|
449 |
Pharmacokinetics of a New Orodispersible Tablet Formulation of Vardenafil
Enthalten in Clinical drug investigation Bd. 31, 24.8.2012, Nr. 1, date:1.2011: 27-41
|
|
|
|
450 |
Pharmacokinetics of Antimalarials in Pregnancy
Enthalten in Clinical pharmacokinetics Bd. 50, 13.9.2012, Nr. 11, date:11.2011: 705-723
|
|
Administration
